Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec;26(12):1038-1041.
doi: 10.1016/j.jmoldx.2024.06.013.

Twenty-Five Years of Germline Genetic Testing and What May Lie Ahead

Victoria M Pratt  1 , Sara Akhavanfard  2 , Jane Houldsworth  3 , Jennifer J Laffin  4 , Ann M Moyer  5 , Honey V Reddi  6 , Stuart A Scott  7 , Matthew S Lebo  8 ; Association for Molecular Pathology Genetics Subdivision Leadership
Collaborators, Affiliations
Editorial

Twenty-Five Years of Germline Genetic Testing and What May Lie Ahead

Victoria M Pratt et al. J Mol Diagn. 2024 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement V.M.P. is the committee chair of the American Medical Association's Proprietary Advisory Group; Associate Editor for The Journal of Molecular Diagnostics; member of the Pharmacogene Variation Consortium Steering Committee, CYP3A, CYP2C; and receives stock through her employer. S.A. is a member of the Cancer Genome Consortium's Annual Meeting Program Committee and American College of Medical Genetics' Differences of Sex Development Evidence Based Guidelines Working Group. J.H. serves as a board member for the Cancer Genomics Consortium and a governing board member of their Development Committee; and is a paid lecturer for Molecular Pathology at the Robert Wood Johnson Medical Center. A.M.M. is a member of ClinPGx's Scientific Advisory Board Committee. H.V.R. is the committee chair for the American College of Medical Genetics and Genomics' Lab QA Molecular Subcommittee; and receives consulting fees from Biofidelity, Inc. S.A.S. is a member of the American College of Medical Genetics and Genomics' Pharmacogenomics Working Group. M.S.L. is a member of the College of American Pathologists' Genomic Medicine Committee; is the Committee Chair for the Clinical Genome Resource's Low Penetrance/Risk Allele Working Group; and is a Co-Investigator on research grants from the NIH. The remaining authors declare no related conflicts of interest.

Publication types

LinkOut - more resources